Aditxt, Inc. financial data

Symbol
ADTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
737 N. Fifth Street, Suite 200, Richmond, VA
State of incorporation
DE
Fiscal year end
December 31
Former names
ADiTx Therapeutics, Inc. (to 7/6/2021), Aditx Therapeutics, Inc. (to 7/6/2021)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 17.9 % -80.2%
Quick Ratio 3.72 %
Debt-to-equity 287 % +31.5%
Return On Equity -607 % +21.9%
Return On Assets -158 % +35.6%
Operating Margin -10.2K % -309%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.6M shares +715%
Common Stock, Shares, Outstanding 1.99M shares -70.5%
Entity Public Float 3.01M USD -62%
Common Stock, Value, Issued 1.99K USD -70.5%
Weighted Average Number of Shares Outstanding, Basic 1.8M shares +1067%
Weighted Average Number of Shares Outstanding, Diluted 1.8M shares +1067%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 330K USD -65.2%
Cost of Revenue 23.1K USD -87.5%
Research and Development Expense 9.7M USD +48.7%
Selling and Marketing Expense 155K USD -78.7%
General and Administrative Expense 18.4M USD +17.5%
Operating Income (Loss) -33.6M USD -42.1%
Nonoperating Income (Expense) -9.66M USD -154%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43.2M USD -57.7%
Net Income (Loss) Attributable to Parent -43M USD -56.9%
Earnings Per Share, Basic -32.2 USD/shares +95.2%
Earnings Per Share, Diluted -32.3 USD/shares +95.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.2K USD -4.93%
Accounts Receivable, after Allowance for Credit Loss, Current 407K USD +7.23%
Inventory, Net 566K USD -44.5%
Assets, Current 1.51M USD -29.8%
Property, Plant and Equipment, Net 1.86M USD -11.4%
Operating Lease, Right-of-Use Asset 1.61M USD -40.4%
Intangible Assets, Net (Excluding Goodwill) 7.78K USD
Other Assets, Noncurrent 348K USD -17.7%
Assets 28.4M USD +289%
Liabilities, Current 20.6M USD +111%
Operating Lease, Liability, Noncurrent 745K USD -47.5%
Liabilities 22M USD +97.4%
Retained Earnings (Accumulated Deficit) -150M USD -40.6%
Stockholders' Equity Attributable to Parent 6.57M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.34M USD
Liabilities and Equity 28.4M USD +289%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.96M USD -50.8%
Net Cash Provided by (Used in) Financing Activities 5.95M USD +299%
Net Cash Provided by (Used in) Investing Activities -5.05K USD +98.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.99M shares -70.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.47M USD +57.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.2K USD -4.93%
Interest Paid, Excluding Capitalized Interest, Operating Activities 623K USD +222%
Deferred Tax Assets, Valuation Allowance 26.4M USD +30.7%
Deferred Tax Assets, Gross 27M USD +28.1%
Operating Lease, Liability 1.48M USD -41.3%
Depreciation 515K USD +14%
Payments to Acquire Property, Plant, and Equipment 5.05K USD
Lessee, Operating Lease, Liability, to be Paid 1.51M USD -44.2%
Property, Plant and Equipment, Gross 3.42M USD +8.78%
Operating Lease, Liability, Current 735K USD -33.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 424K USD -57.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 711K USD +24.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33.7K USD -82.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 424K USD -40.3%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +37.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 424K USD
Additional Paid in Capital 157M USD +52.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 55.7K USD -47.9%
Deferred Tax Assets, Net of Valuation Allowance 630K USD -29.8%
Operating Leases, Future Minimum Payments Due 1.42M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%